Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry
Titel:
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry
Auteur:
Santucci, Jordan Tacey, Mark Thomson, Benjamin Michael, Michael Wong, Rachel Shapiro, Julia Jennens, Ross Clarke, Kate Pattison, Sharon Burge, Matthew Zielinski, Rob Nikfarjam, Mehrdad Ananda, Sumitra Lipton, Lara Gibbs, Peter Lee, Belinda